Effects of PEGylation on biomimetic synthesis of magnetoferritin nanoparticles
Source abstract
Abstract
Recent studies have demonstrated that ferrimagnetic magnetoferritin nanoparticles are a promising novel magnetic nanomaterial in biomedical applications, including biocatalysis, imaging, diagnostics, and tumor therapy. Here we investigated the PEGylation of human H-ferritin (HFn) proteins and the possible influence on biomimetic synthesis of magnetoferritin nanoparticles. The outer surface of HFn proteins was chemically modified with different PEG molecular weights (PEG10K and PEG20K) and different modification ratios (HFn subunit:PEG20K = 1:1, 1:2, 1:4). The PEGylated HFn proteins were used for biomimetic synthesis of ferrimagnetic magnetoferritin nanoparticles. We found that, compared with magnetoferritin using non-PEGylated HFn protein templates, the synthesized magnetoferritin using the PEGylated HFn protein templates possessed larger magnetite cores, higher magnetization and relaxivity values, and improved thermal stability. These results suggest that the PEGylation of H-ferritin may improve the biomineralization of magnetoferritin nanoparticles and enhance their biomedical applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Iron Metabolism and Disorders · Iron oxide chemistry and applications · Hemoglobinopathies and Related Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Aime S, Botta M, Terreno E (2005) Gd(III)-based contrast agents for MRI. Adv Inorg Chem 57:173–237. doi: 10.1016/S0898-8838(05)57004-110.1016/S0898-8838(05)57004-1 ↗
2. Bulte JWM, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484–499. doi: 10.1002/nbm.92410.1002/nbm.924 ↗
3. Burda C, Chen XB, Narayanan R, El-Sayed MA (2005) Chemistry and properties of nanocrystals of different shapes. Chem Rev 105:1025–1102. doi: 10.1021/cr030063a10.1021/cr030063a ↗
4. Burtea C, Laurent S, Roch A, Elst LV, Muller RN (2005) C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. J Inorg Biochem 99(5):1135–1144. doi: 10.1016/j.jinorgbio.2005.02.00910.1016/j.jinorgbio.2005.02.009 ↗
5. Cai Y, Cao CQ, He XQ, Yang CY, Tian LX, Zhu RX, Pan YX (2015) Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size. Int J Nanomedicine 10:2619–2634. doi: 10.2147/Ijn.S8002510.2147/Ijn.S80025 ↗
6. Cao CQ, Tian LX, Liu QS, Liu WF, Chen GJ, Pan YX (2010) Magnetic characterization of noninteracting, randomly oriented, nanometer-scale ferrimagnetic particles. J Geophys Res-Sol Ea 115. doi: 10.1029/2009jb00685510.1029/2009jb006855 ↗
7. Cao CQ, Wang XX, Cai Y, Sun L, Tian LX, Wu H, He XQ, Lei H, Liu WF, Chen GJ, Zhu RX, Pan YX (2014) Targeted in vivo imaging of microscopic tumors with ferritin-based nanoprobes across biological barriers. Adv Mater 26:2566–2571. doi: 10.1002/adma.20130454410.1002/adma.201304544 ↗
8. Castellanos IJ, Crespo R, Griebenow K (2003) Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J Control Release 88:135–145. doi: 10.1016/S0168-3659(02)00488-110.1016/S0168-3659(02)00488-1 ↗
9. Cisowski S (1981) Interacting vs non-interacting single domain behavior in natural and synthetic samples. Phys Earth Planet Inter 26:56–62. doi: 10.1016/0031-9201(81)90097-210.1016/0031-9201(81)90097-2 ↗
10. Delgado C, Francis GE, Fisher D (1992) The uses and properties of PEG-linked proteins. Crit Rev Ther Drug Carrier Syst 9:249–304
11. Ding HL, Zhang YX, Wang S, Xu JM, Xu SC, Li GH (2012) Fe3O4@SiO2 core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses. Chem Mater 24:4572–4580. doi: 10.1021/cm302828d10.1021/cm302828d ↗
12. Douglas T, Dickson DPE, Betteridge S, Charnock J, Garner CD, Mann S (1995) Synthesis and structure of an iron(iii) sulfide-ferritin bioinorganic nanocomposite. Science 269:54–57. doi: 10.1126/science.269.5220.5410.1126/science.269.5220.54 ↗
13. Dreaden EC, Alkilany AM, Huang XH, Murphy CJ, El-Sayed MA (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41:2740–2779. doi: 10.1039/c1cs15237h10.1039/c1cs15237h ↗
14. Falvo E, Tremante E, Fraioli R et al (2013) Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin. Nanoscale 5:12278–12285. doi: 10.1039/c3nr04268e10.1039/c3nr04268e ↗
15. Fan J, Lu J, Xu R, Jiang R, Gao Y (2003) Use of water-dispersible Fe2O3 nanoparticles with narrow size distributions in isolating avidin. J Colloid Interface Sci 266(1):215–218. doi: 10.1016/S0021-9797(03)00570-810.1016/S0021-9797(03)00570-8 ↗
16. Fan K, Cao C, Pan Y et al (2012) Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol 7:459–464. doi: 10.1038/nnano.2012.9010.1038/nnano.2012.90 ↗
17. Fantechi E, Innocenti C, Zanardelli M et al (2014) A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages. ACS Nano 8:4705–4719. doi: 10.1021/nn500454n10.1021/nn500454n ↗
18. Fee CJ, Van Alstine JM (2004) Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins. Bioconjug Chem 15:1304–1313. doi: 10.1021/bc049843w10.1021/bc049843w ↗
19. Gaertner HF, Puigserver AJ (1992) Increased activity and stability of poly(ethylene glycol)-modified trypsin enzyme. Microb Tech 14:150–155. doi: 10.1016/0141-0229(92)90174-M10.1016/0141-0229(92)90174-M ↗
20. Gao JH, Gu HW, Xu B (2009) Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Accounts Chem Res 42:1097–1107. doi: 10.1021/ar900002610.1021/ar9000026 ↗
21. Garcia-Arellano H, Valderrama B, Saab-Rincon G, Vazquez-Duhalt R (2002) High temperature biocatalysis by chemically modified cytochrome c. Bioconjug Chem 13:1336–1344. doi: 10.1021/bc025561p10.1021/bc025561p ↗
22. Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–221. doi: 10.1038/nrd103310.1038/nrd1033 ↗
23. Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275:161–203. doi: 10.1016/0005-2728(96)00022-910.1016/0005-2728(96)00022-9 ↗
24. Harrison PM, Fischbac FA, Hoy TG, Haggis GH (1967) Ferric oxyhydroxide core of ferritin. Nature 216:1188–1190. doi: 10.1038/2161188a010.1038/2161188a0 ↗
25. Hinds KD, Kim SW (2002) Effects of PEG conjugation on insulin properties. Adv Drug Deliver Rev 54:505–530. doi: 10.1016/S0169-409x(02)00025-X10.1016/S0169-409x(02)00025-X ↗
26. Kinstler OB, Brems DN, Lauren SL, Paige AG, Hamburger JB, Treuheit MJ (1996) Characterization and stability of N-terminally PEGylated rhG-CSF. Pharmaceut Res 13:996–1002. doi: 10.1023/A:101604222081710.1023/A:1016042220817 ↗
27. Koenig SH, Kellar KE (1995) Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 34:227–233. doi: 10.1002/mrm.191034021410.1002/mrm.1910340214 ↗
28. Kohler N, Sun C, Fichtenholtz A (2006) Methotrexate-immobilized poly (ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2(6):785–792. doi: 10.1002/smll.20060000910.1002/smll.200600009 ↗
29. Kramer RM, Li C, Carter DC, Stone MO, Naik RR (2004) Engineered protein cages for nanomaterial synthesis. J Am Chem Soc 126:13282–13286. doi: 10.1021/ja046735b10.1021/ja046735b ↗
30. Kurfurst MM (1992) Detection and molecular-weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl-sulfate polyacrylamide-gel electrophoresis. Anal Biochem 200:244–248. doi: 10.1016/0003-2697(92)90460-O10.1016/0003-2697(92)90460-O ↗
31. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2010) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 110:2574–2574. doi: 10.1021/cr900197g10.1021/cr900197g ↗
32. Lu YL, Harding SE, Turner A et al (2008) Effect of PEGylation on the solution conformation of antibody fragments. J Pharm Sci-US 97:2062–2079. doi: 10.1002/jps.2117010.1002/jps.21170 ↗
33. Mann S, Meldrum FC (1991) Controlled synthesis of inorganic materials using supramolecular assemblies. Adv Mater 3:316–318. doi: 10.1002/adma.1991003061110.1002/adma.19910030611 ↗
34. Mann S, Archibald DD, Didymus JM, Douglas T, Heywood BR, Meldrum FC, Reeves NJ (1993) Crystallization at inorganic-organic interfaces-biominerals and biomimetic synthesis. Science 261:1286–1292. doi: 10.1126/science.261.5126.128610.1126/science.261.5126.1286 ↗
35. Matsumura S, Aoki I, Saga T, Shiba K (2011) A tumor-environment-responsive nanocarrier that evolves its surface properties upon sensing matrix metalloproteinase-2 and initiates agglomeration to enhance T2 relaxivity for magnetic resonance imaging. Mol Pharmaceut 8:1970–1974. doi: 10.1021/mp200199910.1021/mp2001999 ↗
36. Meldrum FC, Heywood BR, Mann S (1992) Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 257:522–523. doi: 10.1126/science.163608610.1126/science.1636086 ↗
37. Melnikova L, Pospiskova K, Mitroova Z, Kopcansky P, Safarik I (2014) Peroxidase-like activity of magnetoferritin. Microchim Acta 181:295–301. doi: 10.1007/s00604-013-1105-510.1007/s00604-013-1105-5 ↗
38. Pankhurst Q, Jones S, Dobson J (2016) Applications of magnetic nanoparticles in biomedicine: the story so far. J Phys D Appl Phys 49(50):501002–501003. doi: 10.1088/0022-3727/49/50/50100210.1088/0022-3727/49/50/501002 ↗
39. Readman PW, O'reilly W (1972) Magnetic properties of oxidized (cation-deficient) titanomagnetites (Fe, Ti, □)3O4. J Geomag Geoelectr 24(1):69–90. doi: 10.5636/jgg.24.6910.5636/jgg.24.69 ↗
40. Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54:459–476. doi: 10.1016/j.addr.2012.09.02510.1016/j.addr.2012.09.025 ↗
41. Rodriguez-Martinez JA, Rivera-Rivera I, Sola RJ, Griebenow K (2009) Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates. Biotechnol Lett 31:883–887. doi: 10.1007/s10529-009-9947-y10.1007/s10529-009-9947-y ↗
42. Theil EC (1987) Ferritin-structure, gene-regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 56:289–315. doi: 10.1146/annurev.biochem.56.1.28910.1146/annurev.biochem.56.1.289 ↗
43. Treethammathurot B, Ovartlarnporn C, Wungsintaweekul J, Duncan R, Wiwattanapatapee R (2008) Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin. Int J Pharmaceut 357:252–259. doi: 10.1016/j.ijpharm.2008.01.01610.1016/j.ijpharm.2008.01.016 ↗
44. Tromsdorf UI, Bruns OT, Salmen SC, Beisiegel U, Weller H (2009) A highly effective, nontoxic T-1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett 9:4434–4440. doi: 10.1021/nl902715v10.1021/nl902715v ↗
45. Tsukamoto R, Muraoka M, Fukushige Y, Nakagawa H, Kawaguchi T, Nakatsuji Y, Yamashita I (2008) Improvement of Co3O4 nanoparticle synthesis in apoferritin cavity by outer surface pegylation. B Chem Soc Jpn 81:1669–1674. doi: 10.1246/bcsj.81.166910.1246/bcsj.81.1669 ↗
46. Uchida M, Flenniken ML, Allen M et al (2006) Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 128:16626–16633. doi: 10.1021/ja065569010.1021/ja0655690 ↗
47. Uchida M, Terashima M, Cunningham CH et al (2008) A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 60:1073–1081. doi: 10.1002/mrm.2176110.1002/mrm.21761 ↗
48. Uchio T, Baudys M, Liu F, Song SC, Kim SW (1999) Site-specific insulin conjugates with enhanced stability and extended action profile. Adv Drug Deliver Rev 35:289–306. doi: 10.1016/S0169-409x(98)00078-710.1016/S0169-409x(98)00078-7 ↗
49. Vannucci L, Falvo E, Fornara M et al (2012) Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. Int J Nanomedicine 7:1489–1509. doi: 10.2147/Ijn.S2824210.2147/Ijn.S28242 ↗
50. Veronese FM (2001) Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22:405–417. doi: 10.1016/S0142-9612(00)00193-910.1016/S0142-9612(00)00193-9 ↗
51. Walls MG, Cao CQ, Kui YZ, Li JH, Che RC, Pan YX (2013) Identification of ferrous-ferric Fe3O4 nanoparticles in recombinant human ferritin cages. Microsc Microanal 19:835–841. doi: 10.1017/S143192761300172410.1017/S1431927613001724 ↗
52. Wynn TT, Gumuscu B (2016) Potential role of a new PEGylated recombinant factor VIII for hemophilia a. Journal of blood medicine 7:121–128. doi: 10.2147/JBM.S8245710.2147/JBM.S82457 ↗
53. Yamashita I, Hayashi J, Hara M (2004) Bio-template synthesis of uniform CdSe nanoparticles using cage-shaped protein, apoferritin. Chem Lett 33:1158–1159. doi: 10.1246/Cl.2004.115810.1246/Cl.2004.1158 ↗
54. Yu XG, Marks TJ, Facchetti A (2016) Metal oxides for optoelectronic applications. Nat Mater 15:383–396. doi: 10.1038/NMAT459910.1038/NMAT4599 ↗
55. Zhang ZD, He ZM, Guan GQ (1999) Thermal stability and thermodynamic analysis of native and methoxypolyethylene glycol modified trypsin. Biotechnol Tech 13:781–786. doi: 10.1023/A:100890080432010.1023/A:1008900804320 ↗
56. Zhang T, Cao C, Tang X, Cai Y, Yang C, Pan Y (2017) Enhanced peroxidase activity and tumour tissue visualization by cobalt-doped magnetoferritin nanoparticles. Nanotechnology 28:045704. doi: 10.1088/1361-6528/28/4/04570410.1088/1361-6528/28/4/045704 ↗